Arsenicosis: Diagnosis and treatment

Indian Journal of Dermatology, Venereology and Leprology

Volumn 74, Issue 6, 2008, Pages 571-581

  Das, Nilay ^a,c   Sengupta, Sujit ^b  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c NONE   (India)

Author keywords

Arsenicosis; Chronic arsenic ingestion

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMITRIPTYLINE; ANTIOXIDANT; ARSENIC; ASCORBIC ACID; BIOLOGICAL MARKER; BLACK TEA EXTRACT; CALCIUM CHANNEL BLOCKING AGENT; DRINKING WATER; EICHHORNIA CRASSIPES EXTRACT; GREEN TEA EXTRACT; HISTAMINE H2 RECEPTOR ANTAGONIST; KERATOLYTIC AGENT; METALLOTHIONEIN; PENICILLAMINE; PENTOXIFYLLINE; PLANT EXTRACT; POLYPHENOL; PORPHYRIN; RAIN; RETINOL; SALICYLIC ACID; SELENIUM; SUCCIMER; SURFACE WATER; UNCLASSIFIED DRUG; ZINC;

ARSENIC POISONING; AWARENESS; CHELATION THERAPY; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; COUNSELING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DYSPEPSIA; EICHHORNIA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FLUID INTAKE; FOLLOW UP; HAIR ANALYSIS; HEALTH CARE MANAGEMENT; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; KERATOSIS; LABORATORY DIAGNOSIS; MEDICAL EDUCATION; MEDICAL EXPERT; MELANOSIS; NAIL BED; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PATIENT COUNSELING; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PROTEIN BLOOD LEVEL; PUBLIC HEALTH SERVICE; RISK FACTOR; SECONDARY PREVENTION; SKIN CANCER; SKIN MANIFESTATION; SPINACH; SPIRULINA; SYMPTOM; URINALYSIS; URINE LEVEL; WASTE COMPONENT REMOVAL; WATER CONTAMINATION; WATER TREATMENT;

ANIMALS; ARSENIC; ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; HUMANS; SKIN DISEASES; WATER POLLUTION;

EID: 59149101722     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.45098     Document Type: Conference Paper

References (74)

1. Kapaj S, Peterson H, Liber K, Bhattacharya P. Human health effects from chronic arsenic poisoning: A review. J Environ Sci Health Part A 2006;41:2399-428.
2. Mukherjee A, Sengupta MK, Hossain MA, Ahamed S, Das B, Nayak B, et al. Arsenic contamination in groundwater: A global perspective with emphasis on the Asian scenario. J Health Popul Nutr 2006;24:142-63.
3. Arsenicosis Case-Detection, Management and Surveillance. Report of a Regional Consultation. New Delhi: WHO Regional Office for South-East Asia; June 2003.
4. A field guide for detection, Management and Surveillance of Arsenicosis cases. In: Caussy D, editor. New Delhi: World Health Organization, Regional Office of South-East Asia; 2005.
5. Khan MM, Sakauchi F, Sonoda T, Washio M, Mori M. Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: Evidence from a review of the literature. Asian Pac J Cancer Prev 2003;4:7-14.
6. Mandal NK, Biswas R. A study on arsenical dermatosis in rural community of West Bengal. Indian J Public Health 2004;48:30-3.
7. Saha KC. Diagnosis of arsenicosis. J Environ Sci Health A Tox Hazard Subst Environ Eng 2003;38:255-72.
8. Milton AH, Hasan Z, Rahman A, Rahman M. Non-cancer effects of chronic arsenicosis in Bangladesh: Preliminary results. J Environ Sci Health A Tox Hazard Subst Environ Eng 2003;38:301-5.
9. Kadono T, Inaoka T, Murayama N, Ushijima K, Nagano M, Nakamura S, et al. Skin manifestations of arsenicosis in two villages in Bangladesh. Int J Dermatol 2002;41:841-6.
10. Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate or dimethylarsenate in man. Int Arch Occup Environ Health 1981;48:71-9.
11. Vahter M. Species differences in the metabolism of arsenic compounds. Appl Organomet Chem 1994;8:175-82.
12. Bingham S, Cummings JH. The use of 4-aminobenzic acid as a marker to validate the completenss of 24 h urine collection in man. Clin Sci 1983;64:629-35.
13. Johansson G, Akesson A, Berglund M, Nermell B, Vahter M. Validation with biological markers for food intake of a dietary assessment method used by Swedish women with three different dietary preferences. Public Health Nutr 1998;1:199-206.
14. Calderon RL, Hudgens E, Le XC, Schreinemachers D, Thomas DJ. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect 1999;107:663-7.
15. Guha Mazumder DN. Diagnosis and treatment of chronic arsenic poisoning. Available from: http://www.who.int/entity/water-sanitation-health/dwq/ arsenicun4.pdf. [last accessed 2008 Apr 2].
16. Coccha G, Nermell B, Vahter M. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in North Argentina. Environ Health Perspect 1998;106:355-9.
17. Takagi Y, Matsuda S, Imai S, Ohmori Y, Vinson JA, Mehra MC, et al. Survey of trace elements in human nails: An international comparison. Bull Environ Contam Toxicol 1988;41:690-5.
18. Hindmarsh JT, McCurdy RF. Clinical and environmental aspects of arsenic toxicity. CRC Crit Rev Clin Lab Sci 1986;23:315-47.
19. Pan TC, Lin TH, Tseng CL Yang MH, Huang CW. Trace elements in hair of blackfoot disease. Biol Trace Elem Res 1993;39:117-29.
20. Agahain B, Lee JS, Nelson JH, Johns RE. Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind Hyg Assoc 1990;51:646-51.
21. Hinwood AL, Sim MR, Jolley D, Klerk N, Bastone EB, Gerostamoulos J, et al. Hair and toenail arsenic concentrations of residents living in areas with high environmental arsenic concentrations. Environ Health Perspect 2003;111:187-93.
22. Narang APS, Chawls LS, Khurana SB. Levels of arsenic in Indian opium eaters. Drug Alcohol Depend 1987;20:149-53.
23. Takagi Y, Matsuda S, Imai S, Ohmori Y, Masuda T, Vinson JA, et al. Survey of trace elements in human nails: An international comparison. Bull Environ Contam Toxicol 1988;41:690-5.
24. Pounds CA, Pearson EF, Turner TD. Arsenic in fingernails. J Forensic Sci Soc J 1979;19:165-74.
25. Pirl JN, Townsend GF, Valaitis AK, Grohlich D, Spikes JJ. Death by arsenic: A comparative evaluation of exhumed body tissues in the presence of external contamination. J Anal Toxicol 1983;7:216-9.
26. Hinwood AL, Sim MR, Jolley D, Klerk N, Bastone EB, Gerostamoulos J, et al. Hair and toenail arsenic concentrations of residents living in areas with high environmental arsenic concentrations. Environ Health Perspect 2003;111:187-93.
27. Gomez-Caminero A, Howe P, Hughes M, Kenyon E, Lewis DR, Moore M, et al. Properties and analytical procedures. Arsenic and arsenic compound. Environmental health criteria 224. International programme on chemical safety. Geneva: World Health Organization; 2001. p. 9-27.
28. Baghel A, Singh B, Pandey P, Sekhar K. A rapid field detection method for arsenic in drinking water. Ana Sci 2007;23:135.
29. Cherukurii J, Anjaneyulu Y. Design and development of low cost, simple, rapid and safe, modified field kits for the visual detection and determination of arsenic in drinking water samples. Int J Environ Res Public Health 2005;2:322-7.
30. Deshpande LS, Pande SP. Development of arsenic testing field kit: A tool for rapid on-site screening of arsenic contaminated water sources. Environ Monit Assess 2005;101:93-101.
31. Makris KC, Punamiya P, Sarkar D, Datta R. Novel colorimetric method overcoming phosphorus interference during trace arsenic analysis in soil solution. Analyst 2008;133:191-6.
32. Water-related diseases. Arsenicosis. Available from: https://www.who.int/ water-sanitation-health/diseases/arsenicosis/en/print.html. [last accessed 2008 Apr 2].
33. Deng GD, Zheng BS, Zhai C, Wang JP, Ng JC. Porphyrins as the early biomarkers for arsenic exposure of human. Huan Jing Ke Xue 2007;28:1147-52.
34. Liu J, Cheng ML, Yang Q, Shan KR, Shen J, Zhou Y, et al. Blood metallothionein transcript as a biomarker for metal sensitivity: Low blood metallothionein transcripts in arsenicosis patients from Guizhou, China. Environ Health Perspect 2007;115:1101-6.
35. Wilson R. How can we best provide safe water in Bangladesh? Available from: http://phys4.harvard.edu/~wilson/arsenic-project-introduction.html. [last accessed 2008 Apr 2].
36. van Geen A, Protus T, Cheng Z, Horneman A, Seddique AA, Hoque MA, et al. Testing groundwater for arsenic in Bangladesh before installing a well. Environ Sci Technol 2004;38:6783-9.
37. Cheng Z, van Geen A, Seddique AA, Ahmed KM. Limited temporal variability of arsenic concentrations in 20 wells monitored for 3 years in Araihazar, Bangladesh. Environ Sci Technol 2005;39:4759-66.
38. Hossain MA, Sengupta MK, Ahamed S, Rahman MM, Mondal D, Lodh D, et al. Ineffectiveness and poor reliability of arsenic removal plants in West Bengal, India. Environ Sci Technol 2005;39:4300-6.
39. Milton AH, Hasan Z, Shahidullah SM, Sharmin S, Jakariya MD, Rahman M, et al. Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh. Int J Environ Health Res 2004;14:99-108.
40. Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 1998;27:871-7.
41. Hsueh YM, Cheng GS, Wu MM, Kuo TL, Chen CJ. Multiple risk factors associated with arsenic-induced skin cancer: Effects of chronic liver diseases and malnutritional status. Br J Cancer 1995;71:109-14.
42. Borgono JM, Vicent P, Venturino H, Infante A. Arsenic in the drinking water of the city of antofagasta: Epidemiological and clinical study before and after the installation of the treatment plant. Environ Health Perspect 1977;19:103-5.
43. Spallholz JE, Mallory Boylan L, Rhaman MM. Environmental hypothesis: Is poor dietary selenium intake an underlying factor for arsenicosis and cancer in Bangladesh and West Bengal, India? Sci Total Environ 2004;323:21-32.
44. Wang TS, Kuo CF, Jan KY, Huang H. Arsenite induces apoptosis in Chinese hamser ovary cells by generation of reactive oxygen species. J Cell Physiol 1996;169:256-68.
45. Flora SJ, Flora G, Saxena G, Mishra M. Arsenic and lead induced free radical generation and their reversibility following chelation. Cell Mol Biol 2007;53:26-47.
46. Sinha D, Dey S, Bhattacharya RK, Roy M. In vitro mitigation of arsenic toxicity by tea polyphenols in human lymphocytes. J Environ Pathol Toxicol Oncol 2007;26:207-20.
47. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicol Appl Pharmacol 2007;220:146-55.
48. Ramanathan K, Anusuyadevi M, Shila S, Panneerselvam C. Ascorbic acid and alpha-tocopherol as potent modulators of apoptosis on arsenic induced toxicity in rats. Toxicol Lett 2005;156:297-306.
49. Khandker S, Dey RK, Maidul Islam AZ, Ahmad SA, Mahmud IA. Arsenic-safe drinking water and antioxidants for the management of arsenicosis patients. Bangladesh J Pharmacol 2006;1:42-50.
50. Spallholz JE, Boylan LM, Palace V, Chen J, Smith L, Rahman MM, et al. Arsenic and selenium in human hair: A comparison of five countries with and without arsenicosis. Biol Trace Elem Res 2005;106:133-44.
51. Sikder MS, Islam AZ, Khan MA, Huq MA, Choudhury SA, Misbahuddin M. Effect of spirulina in the treatment of chronic arsenicosis. Bangladesh J Dermatol Venereal Leprol 2000;17: 9-13.
52. Choudhury SA, Khan AK, Misbahuddin M, Islam AZ, Sahjahan M. Role of spirulina in the treatment of chronic arsenic poisoning. Bangladesh Armed Forces Med J 2000;27:181-5.
53. Huq MA, Misbahuddin M, Choudhury SA. Spirulina in the treatment of chronic arsenic poisoning. Bangladesh J Physiol Pharmacol 2000;16:15-6.
54. Misbahuddin M, Islam AZ, Khandker S, Ifthaker-Al-Mahmud, Islam N, Anjumanara. Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: A randomized placebo-controlled study. Clin Toxicol 2006;44:135-41.
55. Umar BU. Effect of hexane extract of spinach in the removal of arsenic from rat. Bangladesh J Pharmacol 2007;2:27-34.
56. Quayum SL. Effect of water hyacinth root extract on arsenic level in different organs of arsenic-treated rat. Bangladesh J Pharmacol 2007;2:73-80
57. Saha KC. Chronic arsenical dermatoses from tube-well water in West Bengal during 1983-87. Indian J Dermatol 1995;40:1-12.
58. Thiaprasit M. Chronic cutaneous arsenism treated with aromatic retinoid. J Med Assoc Thailand 1984;67:93-100.
59. Biczo Z, Berta M, Szabo M, Nagy GY. Traitement de I'arsenicisme chronique par I'etretinate. La Presse Medicale 1986;15:2073.
60. Miller WH. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998;83:1471-82.
61. Wilner C, Low PA. Pharmacological approaches to neuropathic pain In: Dyck PJ, editor. Peripheral neuropathy. WB Saunders: Philadelphia; 1993. p. 1709-20.
62. Hassan MM, Atkins PJ, Dunn CE. Social implications of arsenic poisoning in Bangladesh. Soc Sci Med 2005;61:2201-11.
63. Caldwell BK, Smith WT, Lokuge K, Ranmuthugala G, Dear K, Milton AH, et al. Access to drinking-water and arsenicosis in Bangladesh. J Health Popul Nutr 2006;24:336-45.
64. Hanchett S, Nahar Q, Van Agthoven A, Geers C, Rezvi MD. Increasing awareness of arsenic in Bangladesh: Lessons from a public education programme. Health Policy Plan 2002;17:393-401.
65. Lenz K, Kruby K, Druml W, Eder A, Gaszner A, Kleinberger G, et al. 2,3-Dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol 1981;47:241-63.
66. Shum S, Whitehead J, Vanghn LS, Shum RN, Hale T. Chelation of organo arsenate with Dimercaptosuccinic acid (DMSA). Vet Human Toxicol 1995;37:239-42.
67. Kew J, Morris C, Aihie A, Fysh R, Jones S, Brooks D. Arsenic and mercury intoxication due to Indian ethnic remedies. Br Med J 1993;306:506-7.
68. Guha Mazumder DN, Ghoshal UC, Saha J, Santra A, De BK, Chatterjee A, et al. Randomized placebo-controlled trial of 2,3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water. Clin Toxicol 1998;36:683-90.
69. Mishra D, Mehta A, Flora SJ. Reversal of arsenic-induced hepatic apoptosis with combined administration of DMSA and its analogues in guinea pigs: Role of glutathione and linked enzymes. Chem Res Toxicol 2008;21:400-7.
70. Aposhian HV, Arroyo A, Cebrian ME, Del Razo LZ, Hurlbut KM, Dart RC, et al. DMPS Arsenic challenge test: I Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J Pharm Expt Ther 1997;282:192-200.
71. Maiorino RM, Aposhina HV. Dimercaptan metal binding agents influence the biotransformation of arsenite in the rabbit. Toxicol Appl Pharmacol 1985;77:240-50.
72. Guha Mazumder DN, De BK, Santra A, Ghosh N, Das S, Lahiri S, et al. Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. J Toxicol Clin Toxicol 2001;39:665-74.
73. Bansal SK, Haldar N, Dhand UK, Chopra JS. Phrenic neuropathy in arsenic poisoning. Chest 1991;100:878-80.
74. Kreppel H, Reichl FX, Forth W, Fichtl B. Lack of effectiveness of D-penicillamine in experimental arsenic poisoning. Vet Hum Toxicol 1989;31:1-5.